ETAP
ETAP is a MAO-A and MAO-B inhibitor. ETAP has antidepressant-like effect. ETAP can be used for research of major depressive disorder[1].
Product Specifications
CAS Number
2575731-47-2
UNSPSC
12352005
Target
Monoamine Oxidase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/etap.html
Solubility
10 mM in DMSO
Smiles
CC(C1=CC=CC=C1N2N=NC(C3=CC=C(CC)C=C3)=C2)=O
Molecular Formula
C18H17N3O
Molecular Weight
291.35
References & Citations
[1]Presa MH, et al. Antidepressant-like Effect of 1- (2- (4- (4-Ethylphenyl) -1H-1,2,3-triazol-1-yl) phenyl) ethan-1-one in Mice: Evidence of the Contribution of the Serotonergic System. ACS Chem Neurosci. 2023 Jun 21;14 (12) :2333-2346.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
248874-APC 100 µL
MRE11A (MRE11 meiotic recombination 11 Homolog A (S. cerevisiae), ATLD, HNGS1, MRE11, MRE11B) (APC)
Sign In for Pricing
View Details 